We are delighted to announce that our esteemed CSO, Dr. Zahra Dantes, has been invited to speak at the LSCCB symposium as a distinguished guest. The focus of the talk will be the “Onco-PDO Test Utilizing Patient-Derived Organoids (PDOs) in Supporting Next-Generation Precision Oncology for Cancer Patients“. We are proud that our cutting-edge technology and innovative approach to personalized oncology have garnered the recognition of the LSCCB symposium, and we are excited to share our knowledge with other experts in the field.
Dr. Zahra Dantes; 11.45am – 12:10pm; 18th May 2023
Topic : “Onco-PDO® Test Utilizing Patient-Derived Organoids (PDOs) Supports Next-Generation Precision Oncology in Cancer Patients”
Dr. Rafael Rosell; 2:30pm – 3pm; 18 May 2023
Topic : “Ferroptosis-based therapeutic approaches in Non-Small-Cell Lung Cancer (NSCLC)”
Full Itinerary of LSCCB Symposium 2023 below.
Confirmed-itinerary_LSCCB-Symposium-2023_20230504*We regret to inform the organizer does not have online participation or webinar attendance for this event.